Covariance Labs Inc. — Form D
Covariance Labs Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2026-03-09. The offering totals $11.0M, of which $11.0M was reported sold. Industry: Other Technology.
Offering
- Filed: 2026-03-09
- Form: D
- Accession: 0001231919-26-000240
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $11.0M
- Amount sold: $11.0M
- Investors: 6
- Date of first sale: 2026-01-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-575815
Issuer
- Name: Covariance Labs Inc.
- CIK: 0002116173
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 1350 AVENUE OF THE AMERICAS, SUITE 1720, NEW YORK, NY, 10019
- Phone: 9147210835
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Michael Fleder | Director | New York, NY |
| Thomas Jermoluk | Director | New York, NY |
| Michael Fleder | Executive Officer | New York, NY |
More